Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07276347 · ClinicalTrials.gov registry record · NA

Comprehensive Assessment of Multiple Products (CAMP)

A NA study of Myopia and Hyperopia, sponsored by CooperVision International Limited (CVIL).

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT07276347 is a NA study of Myopia and Hyperopia that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 250 participants, roughly in line with the 265-participant average among 90 other Myopia trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07276347, a NA study of Myopia and Hyperopia, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to assess contact lens performance and acceptance.

Conditions Studied

Myopia Hyperopia

Interventions

  • DEVICE somofilcon A lens
  • DEVICE stenfilcon A lens
  • DEVICE fanfilcon A lens
  • DEVICE comfilcon A lens
  • DEVICE verofilcon A lens

Study Locations (1)

Indiana

  • Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-12
Est. Completion 2026-09
Phase NA

Sponsor

CooperVision International Limited (CVIL)

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07276347

The ClinicalTrials.gov registry entry for NCT07276347 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 265-participant average among 90 other Myopia trials with a reported enrollment target. The listed sponsor is CooperVision International Limited (CVIL), which has 11 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 5 interventions - of which somofilcon A lens is the first listed.

NCT07276347 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07276347 about?

NCT07276347 is a clinical study titled "Comprehensive Assessment of Multiple Products (CAMP)". The aim of this study is to assess contact lens performance and acceptance.

What is the current status of trial NCT07276347?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-12. Estimated completion is 2026-09.

What conditions does trial NCT07276347 study?

This clinical trial studies the following conditions: Myopia, Hyperopia.

What interventions are being tested in trial NCT07276347?

The interventions under investigation include: somofilcon A lens (DEVICE), stenfilcon A lens (DEVICE), fanfilcon A lens (DEVICE), comfilcon A lens (DEVICE), verofilcon A lens (DEVICE).

Who is sponsoring clinical trial NCT07276347?

This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07276347 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

Hyperopia

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.